Dubuque Bank & Trust’s Abiomed Inc ABMD Stock Holding History

Dubuque Bank & Trust’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-30	Closed	-$9K	–	645
2019 Q1	$9K	Buy	+30	New	+$9.97K	﹤0.01%	494

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Dubuque Bank & Trust's ABMD Position: Q2 2019 in Review

Dubuque Bank & Trust sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 30 shares — an estimated $9K sold.

Dubuque Bank & Trust first reported a position in ABMD in Q1 2019 and held it in 1 quarter. The position peaked at $9K in Q1 2019. 483 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

Dubuque Bank & Trust reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
Dubuque Bank & Trust sold 30 Abiomed Inc shares in Q2 2019, an estimated $9K.
Dubuque Bank & Trust first reported a position in Abiomed Inc in Q1 2019 and held it in 1 quarter.
Dubuque Bank & Trust's Abiomed Inc position peaked at $9K in Q1 2019.
483 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Dubuque Bank & Trust's 13F filing for Q2 2019, filed 10 Jul 2019.